Tag: proscar
-
FDA committee votes down 5-ARIs for prostate cancer risk reduction – – UrologyTimes
“Although the REDUCE trial demonstrated a risk reduction in a large number of men, the committee chose to focus on a small number of high-grade cancers and determined that this class of drugs is inappropriate for prostate cancer risk reduction, even in the population of men with elevated PSA and previous negative biopsy,” added Dr.…